Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study

References

• Rader RA, Langer ES. 30 years of upstream productivity improvements. Bioprocess Int. 2015;13. https://bioprocessintl.com/upstream-processing/expression-platforms/30-years-upstream-productivity-improvements/.
   Google Scholar
• Xu J, Rehmann MS, Xu X, Huang C, Tian J, Qian NX, Li ZJ. Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media. mAbs. 2018;10:488–13. doi:https://doi.org/10.1080/19420862.2018.1433978.
   PubMed Web of Science ®Google Scholar
• Xu J, Tang P, Yongky A, Drew B, Borys MC, Liu S, Li ZJ. Systematic development of temperature shift strategies for Chinese hamster ovary cells based on short duration cultures and kinetic modeling. mAbs. 2019;11:191–204. doi:https://doi.org/10.1080/19420862.2018.1525262.
   PubMed Web of Science ®Google Scholar
• Li F, Vijayasankaran N, Shen AY, Kiss R, Amanullah A. Cell culture processes for monoclonal antibody production. mAbs. 2010;2:466–77. doi:https://doi.org/10.4161/mabs.2.5.12720.
   PubMed Web of Science ®Google Scholar
• Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22:1393–98. doi:https://doi.org/10.1038/nbt1026.
   PubMed Web of Science ®Google Scholar
• Rader RA. Current challenges in bioprocesses development. Pharm Technol Eur. 2018;30:12–13.
   Google Scholar
• Godawat R, Konstantinov K, Rohani M, Warikoo V. End-to-end integrated fully continuous production of recombinant monoclonal antibodies. J Biotechnol. 2015;213:13–19. doi:https://doi.org/10.1016/j.jbiotec.2015.06.393.
   PubMed Web of Science ®Google Scholar
• Strube J, Ditz R, Kornecki M, Huter M, Schmidt A, Thiess H, Zobel-Roos S. Process intensification in biologics manufacturing. Chem Eng Process. 2018;133:278–93. doi:https://doi.org/10.1016/j.cep.2018.09.022.
   Web of Science ®Google Scholar
• Bielser JM, Wolf M, Souquet J, Broly H, Morbidelli M. Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review. Biotechnol Adv. 2018;36:1328–40. doi:https://doi.org/10.1016/j.biotechadv.2018.04.011.
   PubMed Web of Science ®Google Scholar
• Pleitt K, Somasundaram B, Johnson B, Shave E, Lua LHL. Evaluation of process simulation as a decisional tool for biopharmaceutical contract development and manufacturing organizations. Biochem Eng J. 2019;150. DOI:https://doi.org/10.1016/j.bej.2019.107252.
   Google Scholar
• Gomez N, Lull J, Yang X, Wang Y, Zhang X, Wieczorek A, Harrahy J, Pritchard M, Cano DM, Shearer M. Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles. Biotechnol Prog. 2020. (In press). doi:https://doi.org/10.1002/btpr.2973.
   Google Scholar
• Moulijn JA, Stankiewicz A. Process intensification. In: Encyclopedia of sustainable technologies. Elsevier; 2017. p. 509–18.
   Google Scholar
• Stankiewicz AI, Moulijn JA. Process intensification: transforming chemical engineering. Chem Eng Prog. 2000;96:22–33.
   Web of Science ®Google Scholar
• Chotteau V, Zhang Y, Clincke MF. Very high cell density in perfusion of CHO cells by ATF, TFF, wave bioreactor, and/or celltank technologies - impact of cell density and applications. In: Subramanian G, editor. Continuous processing in pharmaceutical manufacturing. Wiley Blackwell; 2015. p. 339–56. DOI: https://doi.org/10.1002/9783527673681.ch13.
   Google Scholar
• Voisard D, Meuwly F, Ruffieux PA, Baer G, Kadouri A. Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol Bioeng. 2003;82:751–65. doi:https://doi.org/10.1002/bit.10629.
   PubMed Web of Science ®Google Scholar
• Kelley B, Kiss R, Laird M. A different perspective: how much innovation is really needed for monoclonal antibody production using mammalian cell technology? Adv Biochem Eng/Biotechnol. 2018;165:443–462. DOI:https://doi.org/10.1007/10_2018_59.
   Google Scholar
• Croughan MS, Konstantinov KB, Cooney C. The future of industrial bioprocessing: batch or continuous? Biotechnol Bioeng. 2015;112:648–51. doi:https://doi.org/10.1002/bit.25529.
   PubMed Web of Science ®Google Scholar
• Yongky A, Xu J, Tian J, Oliveira C, Zhao J, McFarland K, Borys MC, Li ZJ. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures. mAbs. 2019;11:1502–14. doi:https://doi.org/10.1080/19420862.2019.1652075.
   PubMed Web of Science ®Google Scholar
• Warikoo V, Godawat R, Brower K, Jain S, Cummings D, Simons E, Johnson T, Walther J, Yu M, Wright B. Integrated continuous production of recombinant therapeutic proteins. Biotechnol Bioeng. 2012;109(12):3018–29. doi:https://doi.org/10.1002/bit.24584.
   PubMed Web of Science ®Google Scholar
• Vogel JH, Nguyen H, Giovannini R, Ignowski J, Garger S, Salgotra A, Tom J. A new large-scale manufacturing platform for complex biopharmaceuticals. Biotechnol Bioeng. 2012;109(12):3049–58. doi:https://doi.org/10.1002/bit.24578.
   PubMed Web of Science ®Google Scholar
• Yang WC, Lu J, Kwiatkowski C, Yuan H, Kshirsagar R, Ryll T, Huang Y-M. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality. Biotechnol Prog. 2014;30:616–25. doi:https://doi.org/10.1002/btpr.1884.
   PubMed Web of Science ®Google Scholar
• Padawer I, Ling WLW, Bai Y. Case study: an accelerated 8-day monoclonal antibody production process based on high seeding densities. Biotechnol Prog. 2013;29:829–32. doi:https://doi.org/10.1002/btpr.1719.
   PubMed Web of Science ®Google Scholar
• Pohlscheidt M, Jacobs M, Wolf S, Thiele J, Jockwer A, Gabelsberger J, Jenzsch M, Tebbe H, Burg J. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors. Biotechnol Prog. 2013;29:222–29. doi:https://doi.org/10.1002/btpr.1672.
   PubMed Web of Science ®Google Scholar
• Jordan M, Mac Kinnon N, Monchois V, Stettler M, Broly H. Intensification of large-scale cell culture processes. Curr Opin Chem Eng. 2018;22:253–57. doi:https://doi.org/10.1016/j.coche.2018.11.008.
   Web of Science ®Google Scholar
• Woodgate JM. Perfusion N-1 culture-opportunities for process intensification. Biopharmaceutical processing: development, design, and implementation of manufacturing processes. Elsevier; 2018. p. 755–68. DOI:https://doi.org/10.1016/B978-0-08-100623-8.00037-2.
   Google Scholar
• Xu J, Rehmann MS, Xu M, Zheng S, Hill C, He Q, Borys MC, Li ZJ. Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing. Bioresources Bioprocess. 2020;7(1):17. doi:https://doi.org/10.1186/s40643-020-00304-y.
   Web of Science ®Google Scholar
• Huang YM, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog. 2010;26:1400–10. doi:https://doi.org/10.1002/btpr.436.
   PubMed Web of Science ®Google Scholar
• Ghose S, Zhang J, Conley L, Caple R, Williams KP, Cecchini D. Maximizing binding capacity for protein A chromatography. Biotechnol Prog. 2014;30:1335–40. doi:https://doi.org/10.1002/btpr.1980.
   PubMed Web of Science ®Google Scholar
• Pabst TM, Thai J, Hunter AK. Evaluation of recent Protein A stationary phase innovations for capture of biotherapeutics. J Chromatogr A. 2018;1554:45–60. doi:https://doi.org/10.1016/j.chroma.2018.03.060.
   PubMed Web of Science ®Google Scholar
• Zhang J, Conley L, Pieracci J, Ghose S. Pool-less processing to streamline downstream purification of monoclonal antibodies. Eng Life Sci. 2017;17:117–24. doi:https://doi.org/10.1002/elsc.201600104.
   PubMed Web of Science ®Google Scholar
• Godawat R, Brower K, Jain S, Konstantinov K, Riske F, Warikoo V. Periodic counter-current chromatography - design and operational considerations for integrated and continuous purification of proteins. Biotechnol J. 2012;7:1496–508. doi:https://doi.org/10.1002/biot.201200068.
   PubMed Web of Science ®Google Scholar
• Pollock J, Bolton G, Coffman J, Ho SV, Bracewell DG, Farid SS. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. J Chromatogr A. 2013;1284:17–27. doi:https://doi.org/10.1016/j.chroma.2013.01.082.
   PubMed Web of Science ®Google Scholar
• Angarita M, Müller-Späth T, Baur D, Lievrouw R, Lissens G, Morbidelli M. Twin-column CaptureSMB: A novel cyclic process for protein A affinity chromatography. J Chromatogr A. 2015;1389:85–95. doi:https://doi.org/10.1016/j.chroma.2015.02.046.
   PubMed Web of Science ®Google Scholar
• Khanal O, Kumar V, Westerberg K, Schlegel F, Lenhoff AM. Multi-column displacement chromatography for separation of charge variants of monoclonal antibodies. J Chromatogr A. 2019;1586:40–51. doi:https://doi.org/10.1016/j.chroma.2018.11.074.
   PubMed Web of Science ®Google Scholar
• Orozco R, Godfrey S, Coffman J, Amarikwa L, Parker S, Hernandez L, Wachuku C, Mai B, Song B, Hoskatti S. Design, construction, and optimization of a novel, modular, and scalable incubation chamber for continuous viral inactivation. Biotechnol Prog. 2017;33:954–65. doi:https://doi.org/10.1002/btpr.2442.
   PubMed Web of Science ®Google Scholar
• Gillespie C, Holstein M, Mullin L, Cotoni K, Tuccelli R, Caulmare J, Greenhalgh P. Continuous In-Line Virus Inactivation for Next Generation Bioprocessing. Biotechnol J. 2019;14(2):1700718. doi:https://doi.org/10.1002/biot.201700718.
   Web of Science ®Google Scholar
• David L, Maiser B, Lobedann M, Schwan P, Lasse M, Ruppach H, Schembecker G. Virus study for continuous low pH viral inactivation inside a coiled flow inverter. Biotechnol Bioeng. 2019;116(4):857–69. doi:https://doi.org/10.1002/bit.26872.
   PubMed Web of Science ®Google Scholar
• Rucker-Pezzini J, Arnold L, Hill-Byrne K, Sharp T, Avazhanskiy M, Forespring C. Single pass diafiltration integrated into a fully continuous mAb purification process. Biotechnol Bioeng. 2018;115:1949–57. doi:https://doi.org/10.1002/bit.26708.
   PubMed Web of Science ®Google Scholar
• David L, Niklas J, Budde B, Lobedann M, Schembecker G. Continuous viral filtration for the production of monoclonal antibodies. Chem Eng Res Des. 2019;152:336–47. doi:https://doi.org/10.1016/j.cherd.2019.09.040.
   Web of Science ®Google Scholar
• Baur D, Angarita M, Müller-Späth T, Steinebach F, Morbidelli M. Comparison of batch and continuous multi-column protein A capture processes by optimal design. Biotechnol J. 2016;11:920–31. doi:https://doi.org/10.1002/biot.201500481.
   PubMed Web of Science ®Google Scholar
• Klutz S, Magnus J, Lobedann M, Schwan P, Maiser B, Niklas J, Temming M, Schembecker G. Developing the biofacility of the future based on continuous processing and single-use technology. J Biotechnol. 2015;213:120–30. doi:https://doi.org/10.1016/j.jbiotec.2015.06.388.
   PubMed Web of Science ®Google Scholar
• Arnold L, Lee K, Rucker-Pezzini J, Lee JH. Implementation of fully integrated continuous antibody processing: effects on productivity and COGm. Biotechnol J. 2019;14:1800061. doi:https://doi.org/10.1002/biot.201800061.
   Web of Science ®Google Scholar
• Steinebach F, Ulmer N, Wolf M, Decker L, Schneider V, Wälchli R, Karst D, Souquet J, Morbidelli M. Design and operation of a continuous integrated monoclonal antibody production process. Biotechnol Prog. 2017;33:1303–13. doi:https://doi.org/10.1002/btpr.2522.
   PubMed Web of Science ®Google Scholar
• Badman C, Cooney CL, Florence A, Konstantinov K, Krumme M, Mascia S, Nasr M, Trout BL. Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen. J Pharm Sci. 2019;108(11):3521–23. doi:https://doi.org/10.1016/j.xphs.2019.07.016.
   PubMed Web of Science ®Google Scholar
• Rathore AS, Kateja N, Kumar D. Process integration and control in continuous bioprocessing. Curr Opin Chem Eng. 2018;22:18–25. doi:https://doi.org/10.1016/j.coche.2018.08.005.
   Web of Science ®Google Scholar
• Fan L, Kadura I, Krebs LE, Hatfield CC, Shaw MM, Frye CC. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Biotechnol Bioeng. 2012;109:1007–15. doi:https://doi.org/10.1002/bit.24365.
   PubMed Web of Science ®Google Scholar
• Lin PC, Chan KF, Kiess IA, Tan J, Shahreel W, Wong SY, Song Z. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics. mAbs. 2019;11:965–76. doi:https://doi.org/10.1080/19420862.2019.1612690.
   PubMed Web of Science ®Google Scholar
• McHugh KP, Xu J, Aron KL, Borys MC, Li ZJ. Effective temperature shift strategy development and scale confirmation for simultaneous optimization of protein productivity and quality in Chinese hamster ovary cells. Biotechnol Prog. 2020. In press. doi:https://doi.org/10.1002/btpr.2959.
   Google Scholar
• Zhu MM, Goyal A, Rank DL, Gupta SK, Vanden Boom T, Lee SS. Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: A case study. Biotechnol Prog. 2005;21:70–77. doi:https://doi.org/10.1021/bp049815s.
   PubMed Web of Science ®Google Scholar
• Goetze AM, Liu YD, Zhang Z, Shah B, Lee E, Bondarenko PV, Flynn GC. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology. 2011;21:949–59. doi:https://doi.org/10.1093/glycob/cwr027.
   PubMed Web of Science ®Google Scholar
• Baur D, Angelo J, Chollangi S, Müller-Späth T, Xu X, Ghose S, Li ZJ, Morbidelli M. Model-assisted process characterization and validation for a continuous two-column protein A capture process. Biotechnol Bioeng. 2019;116(1):87–98. doi:https://doi.org/10.1002/bit.26849.
   PubMed Web of Science ®Google Scholar
• Ichihara T, Ito T, Kurisu Y, Galipeau K, Gillespie C. Integrated flow-through purification for therapeutic monoclonal antibodies processing. mAbs. 2018;10:325–34. doi:https://doi.org/10.1080/19420862.2017.1417717.
   PubMed Web of Science ®Google Scholar
• Handlogten MW, Lee-O’Brien A, Roy G, Levitskaya SV, Venkat R, Singh S, Ahuja S. Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Biotechnol Bioeng. 2018;115:126–38. doi:https://doi.org/10.1002/bit.26460.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Kikuchi T, Wada R, Omasa T. The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside. Cytotechnology. 2017;69:511–21. doi:https://doi.org/10.1007/s10616-017-0066-7.
   PubMed Web of Science ®Google Scholar
• Gronemeyer P, Ditz R, Strube J. DoE based integration approach of upstream and downstream processing regarding HCP and ATPE as harvest operation. Biochem Eng J. 2016;113:158–66. doi:https://doi.org/10.1016/j.bej.2016.06.016.
   Web of Science ®Google Scholar
• Angelo J, Chollangi S, Müller-Späth T, Jusyte S, Xu X, Ghose S, Li Z. Virus clearance validation across continuous capture chromatography. Biotechnol Bioeng. 2019;116:2275–84. doi:https://doi.org/10.1002/bit.27012.
   PubMed Web of Science ®Google Scholar
• Chiang MJ, Pagkaliwangan M, Lute S, Bolton G, Brorson K, Schofield M. Validation and optimization of viral clearance in a downstream continuous chromatography setting. Biotechnol Bioeng. 2019;116:2292–302. doi:https://doi.org/10.1002/bit.27023.
   PubMed Web of Science ®Google Scholar